Movatterモバイル変換


[0]ホーム

URL:


AU6080294A - Antisense molecules directed against genes of the (raf) oncogene family - Google Patents

Antisense molecules directed against genes of the (raf) oncogene family

Info

Publication number
AU6080294A
AU6080294AAU60802/94AAU6080294AAU6080294AAU 6080294 AAU6080294 AAU 6080294AAU 60802/94 AAU60802/94 AAU 60802/94AAU 6080294 AAU6080294 AAU 6080294AAU 6080294 AAU6080294 AAU 6080294A
Authority
AU
Australia
Prior art keywords
raf
directed against
antisense molecules
oncogene family
molecules directed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU60802/94A
Inventor
Larry A Denner
Richard A.F. Dixon
Ajay A Rege
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Encysive Pharmaceuticals Inc
Original Assignee
Texas Biotechnology Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Texas Biotechnology CorpfiledCriticalTexas Biotechnology Corp
Publication of AU6080294ApublicationCriticalpatent/AU6080294A/en
Abandonedlegal-statusCriticalCurrent

Links

Classifications

Landscapes

AU60802/94A1992-12-311993-12-28Antisense molecules directed against genes of the (raf) oncogene familyAbandonedAU6080294A (en)

Applications Claiming Priority (3)

Application NumberPriority DateFiling DateTitle
US99971092A1992-12-311992-12-31
US9997101992-12-31
PCT/US1993/012603WO1994015645A1 (en)1992-12-311993-12-28Antisense molecules directed against genes of the raf oncogene family

Publications (1)

Publication NumberPublication Date
AU6080294Atrue AU6080294A (en)1994-08-15

Family

ID=25546620

Family Applications (1)

Application NumberTitlePriority DateFiling Date
AU60802/94AAbandonedAU6080294A (en)1992-12-311993-12-28Antisense molecules directed against genes of the (raf) oncogene family

Country Status (2)

CountryLink
AU (1)AU6080294A (en)
WO (1)WO1994015645A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
AU689267B2 (en)*1994-05-311998-03-26Isis Pharmaceuticals, Inc.Antisense oligonucleotide modulation of RAF gene expression

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
JPH08505397A (en)*1993-01-071996-06-11トーマス ジェファーソン ユニバーシティ Antisense inhibition of c-myc to regulate smooth muscle cell proliferation.
US6133242A (en)*1993-10-152000-10-17Thomas Jefferson UniverisityInhibition of extracellular matrix synthesis by antisense compounds directed to nuclear proto-oncogenes
US6323184B1 (en)1993-10-152001-11-27Thomas Jefferson UniversityArteriovenous and venous graft treatments: methods and compositions
US5656612A (en)*1994-05-311997-08-12Isis Pharmaceuticals, Inc.Antisense oligonucleotide modulation of raf gene expression
US6410518B1 (en)1994-05-312002-06-25Isis Pharmaceuticals, Inc.Antisense oligonucleotide inhibition of raf gene expression
US6090626A (en)*1994-05-312000-07-18Isis Pharmaceuticals Inc.Antisense oligonucleotide modulation of raf gene expression
US6358932B1 (en)1994-05-312002-03-19Isis Pharmaceticals, Inc.Antisense oligonucleotide inhibition of raf gene expression
KR100211178B1 (en)*1994-05-311999-07-15파샬 비. 린네 Antisense Oligonucleotide Regulation of Rafgene Expression
US5744362A (en)*1994-05-311998-04-28Isis Pharmaceuticals, Inc.Antisense oligonucleotide modulation of raf gene expression
WO1997032604A1 (en)*1996-03-071997-09-12Novartis AgAntiproliferative combinations, containing raf-targeted oligonucleotides and chemotherapeutic compounds
US5744460A (en)*1996-03-071998-04-28Novartis CorporationCombination for treatment of proliferative diseases
US6803360B1 (en)1996-12-302004-10-12Georgetown UniversityCompositions and methods for reducing radiation and drug resistance in cells
US7262173B2 (en)1997-03-212007-08-28Georgetown UniversityChemosensitizing with liposomes containing oligonucleotides
EP1173254A2 (en)*1999-04-272002-01-23Smithkline Beecham PlcNovel treatment of neurotraumatic conditions with a raf inhibitor
PT1309726E (en)2000-03-302010-03-08Whitehead Biomedical Inst RNA INTERFERENCE-SPECIFIC RNA INTERFERENCE MEDIATORS
DE10020138A1 (en)*2000-04-142001-10-31Ulf R Rapp Nucleic acid coding for at least one partial sequence with a MEKK1 binding site
CA2429814C (en)2000-12-012014-02-18Thomas TuschlRna interference mediating small rna molecules
WO2002081642A2 (en)2001-04-062002-10-17Georgetown UniversityGene brcc-3 and diagnostic and therapeutic uses thereof
WO2002081639A2 (en)2001-04-062002-10-17Georgetown UniversityGene brcc2 and diagnostic and therapeutic uses thereof
AU2002305151A1 (en)2001-04-062002-10-21Georgetown UniversityGene scc-112 and diagnostic and therapeutic uses thereof
US7138512B2 (en)2002-04-102006-11-21Georgetown UniversityGene SHINC-2 and diagnostic and therapeutic uses thereof
US7244565B2 (en)2002-04-102007-07-17Georgetown UniversityGene shinc-3 and diagnostic and therapeutic uses thereof
US20050148528A1 (en)*2002-05-202005-07-07Neopharm, IncMethod for reducing platelet count

Cited By (1)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
AU689267B2 (en)*1994-05-311998-03-26Isis Pharmaceuticals, Inc.Antisense oligonucleotide modulation of RAF gene expression

Also Published As

Publication numberPublication date
WO1994015645A1 (en)1994-07-21

Similar Documents

PublicationPublication DateTitle
AU6080294A (en)Antisense molecules directed against genes of the (raf) oncogene family
AU4651893A (en)Novel tyrosine kinase
AU5616794A (en)Chemical vessel environmental chamber
AU4794593A (en)Antisense viruses and antisense-ribozyme viruses
HK1003588B (en)Immersion heaters
AU586398B2 (en)Polyamine-polyene ultraviolet coatings
AU5568694A (en)Stable oligonucleotides
EP0516958A3 (en)Caffeoyl-coa-3-o-methyltransferase gene
AU7404794A (en)Cardioplegia filter
AU2880392A (en)Chromatographic separation of phosphorothioate oligonucleotides
AU3730093A (en)Methods of treating diabetes
AU7828991A (en)Improved coatings
HU9500979D0 (en)Antisense oligonucleotide inhibition of the ras gene
AU3729493A (en)Cyclobutyl antisense oligonucleotides, methods of making and use thereof
AU3462193A (en)Polyalkylcyanoacrylate nanocapsules
AU4744893A (en)Sample core stabilization
AU2285592A (en)Improved coating solution
AU5371694A (en)Use of the tarchonanthus camphoratus
AU3292393A (en)Treating liquids
AU1893192A (en)Dna silver staining
AU6679094A (en)Genetic stabilizing elements
AU2294492A (en)Process for the preparation of metal carbides
AU1724492A (en)Eimeria maxima dna probes
AU2387292A (en)Antisense oligonucleotides
AU3604393A (en)Novel gene therapies employing antisense constructs

[8]ページ先頭

©2009-2025 Movatter.jp